Screening by Aurora. During the Collaboration Period, Aurora shall use each Screen validated pursuant to Section 2.2.2 to test the activity of Compounds provided by Allelix or agreed by the parties pursuant to Section 3.1.2. Aurora shall, with regard to each such Screen, screen Compounds as determined by the CC and provide retests of Compounds or putative Hits, and determination of crude IC50's as determined by the CC (the "Screening Program").
Appears in 3 contracts
Sources: Collaboration Agreement (Aurora Biosciences Corp), Collaboration Agreement (Aurora Biosciences Corp), Collaboration Agreement (Aurora Biosciences Corp)